Open Access

Gene expression profiling in bladder cancer identifies potential therapeutic targets

  • Authors:
    • Syed A. Hussain
    • Daniel H. Palmer
    • Wing-Kin Syn
    • Joseph J. Sacco
    • Richard M.D. Greensmith
    • Taha Elmetwali
    • Vijay Aachi
    • Bryony H. Lloyd
    • Puthen V. Jithesh
    • John Arrand
    • Darren Barton
    • Jawaher Ansari
    • D. Ross Sibson
    • Nicholas D. James
  • View Affiliations

  • Published online on: March 2, 2017     https://doi.org/10.3892/ijo.2017.3893
  • Pages: 1147-1159
  • Copyright: © Hussain et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Despite advances in management, bladder cancer remains a major cause of cancer related complications. Characterisation of gene expression patterns in bladder cancer allows the identification of pathways involved in its pathogenesis, and may stimulate the development of novel therapies targeting these pathways. Between 2004 and 2005, cystoscopic bladder biopsies were obtained from 19 patients and 11 controls. These were subjected to whole transcript-based microarray analysis. Unsupervised hierarchical clustering was used to identify samples with similar expression profiles. Hypergeometric analysis was used to identify canonical pathways and curated networks having statistically significant enrichment of differentially expressed genes. Osteopontin (OPN) expression was validated by immunohistochemistry. Hierarchical clustering defined signatures, which differentiated between cancer and healthy tissue, muscle-invasive or non-muscle invasive cancer and healthy tissue, grade 1 and grade 3. Pathways associated with cell cycle and proliferation were markedly upregulated in muscle-invasive and grade 3 cancers. Genes associated with the classical complement pathway were downregulated in non-muscle invasive cancer. Osteopontin was markedly overexpressed in invasive cancer compared to healthy tissue. The present study contributes to a growing body of work on gene expression signatures in bladder cancer. The data support an important role for osteopontin in bladder cancer, and identify several pathways worthy of further investigation.
View Figures
View References

Related Articles

Journal Cover

April-2017
Volume 50 Issue 4

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Hussain SA, Palmer DH, Syn W, Sacco JJ, Greensmith RM, Elmetwali T, Aachi V, Lloyd BH, Jithesh PV, Arrand J, Arrand J, et al: Gene expression profiling in bladder cancer identifies potential therapeutic targets. Int J Oncol 50: 1147-1159, 2017
APA
Hussain, S.A., Palmer, D.H., Syn, W., Sacco, J.J., Greensmith, R.M., Elmetwali, T. ... James, N.D. (2017). Gene expression profiling in bladder cancer identifies potential therapeutic targets. International Journal of Oncology, 50, 1147-1159. https://doi.org/10.3892/ijo.2017.3893
MLA
Hussain, S. A., Palmer, D. H., Syn, W., Sacco, J. J., Greensmith, R. M., Elmetwali, T., Aachi, V., Lloyd, B. H., Jithesh, P. V., Arrand, J., Barton, D., Ansari, J., Sibson, D. R., James, N. D."Gene expression profiling in bladder cancer identifies potential therapeutic targets". International Journal of Oncology 50.4 (2017): 1147-1159.
Chicago
Hussain, S. A., Palmer, D. H., Syn, W., Sacco, J. J., Greensmith, R. M., Elmetwali, T., Aachi, V., Lloyd, B. H., Jithesh, P. V., Arrand, J., Barton, D., Ansari, J., Sibson, D. R., James, N. D."Gene expression profiling in bladder cancer identifies potential therapeutic targets". International Journal of Oncology 50, no. 4 (2017): 1147-1159. https://doi.org/10.3892/ijo.2017.3893